Skip to main content
. 2016 Aug 10;10:1495–1503. doi: 10.2147/OPTH.S110739

Table 1.

Subject demographics, intent-to-treat population

Subject demographics Combination (n=305) 0.1% dexamethasone (n=298) 1% azithromycin (n=155) Vehicle (n=149) All subjects (N=907)
Age (years)
Mean (standard deviation) 59.9 (17.47) 60.8 (16.70) 58.5 (15.77) 60.2 (16.28) 60 (16.74)
Ethnicity
Hispanic or Latino, n (%) 34 (11.1) 35 (11.7) 20 (12.9) 24 (16.1) 113 (12.5)
Not Hispanic or Latino, n (%) 271 (88.9) 263 (88.3) 135 (87.1) 125 (83.9) 794 (87.5)
Race
White, n (%) 261 (85.6) 253 (84.9) 135 (87.1) 132 (88.6) 781 (86.1)
Black or African-American, n (%) 33 (10.8) 32 (10.7) 11 (7.1) 13 (8.7) 89 (9.8)
Asian, n (%) 4 (1.3) 9 (3) 6 (3.9) 3 (2) 22 (2.4)
American Indian or Alaska Native, n (%) 1 (0.3) 1 (0.3) 0 0 2 (0.2)
Native Hawaiian or other Pacific Islander, n (%) 1 (0.3) 0 1 (0.6) 0 2 (0.2)
Other, n (%) 5 (1.6) 3 (1) 2 (1.3) 1 (0.7) 11 (1.2)
Sex
Male, n (%) 134 (43.9) 140 (47) 62 (40) 56 (37.6) 392 (43.2)
Female, n (%) 171 (56.1) 158 (53) 93 (60) 93 (62.4) 515 (56.8)

Note: Combination =0.1% dexamethasone and 1% azithromycin.